Ganymed Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
News Dec 26, 2013
Ganymed Pharmaceuticals AG has announced that it will present at the 32nd Annual J.P. Morgan Healthcare Conference that will take place from January 13 to January 16, 2014 in San Francisco.
Ganymed’s CEO, Dr. Özlem Türeci, will provide an overview of the company’s product pipeline and clinical programs. Her presentation will take place on Tuesday January 14 from 11:30 to 12:00 Pacific Time in the Elizabethan D meeting room of the Westin St. Francis Hotel, San Francisco.
The Annual J.P. Morgan Healthcare Conference is the largest healthcare investment conference, bringing together established industry leaders and emerging fast-growth companies.
Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.